Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Completed
1,916 enrolled
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Unknown
103 enrolled
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
Terminated
2,500 enrolled
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Completed
39 enrolled
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
Completed
247 enrolled
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Recruiting
174 enrolled
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
275 enrolled
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
Completed
50 enrolled
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
Completed
90 enrolled
Research Study in Patients With Advanced Ovarian Epithelial Cancer
Withdrawn
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
Completed
64 enrolled
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
Terminated
Quality of Life in Survivors of Gynecologic Cancer
Completed
311 enrolled
Quality-of-Life Assessment in Patients With Ovarian Cancer
Completed
372 enrolled